By Pat Anson, Editor
Brain imaging could someday be used to help develop new pain medicines and to personalize the treatment of chronic pain patients, according to a small study at the University of Michigan.
MRI scans allow researchers to “see” how a pain medicine works in the brain. Image courtesy of University of Michigan Health System.
Researchers there were the first to use MRI brain imaging to track the clinical action of pregabalin, a drug widely prescribed to treat fibromyalgia and neuropathic pain. Pregabalin is the generic name for Lyrica, which is sold by Pfizer Inc. (NYSE: PFE).
Three different types of brain imaging were used – proton magnetic resonance spectroscopy, functional magnetic resonance imaging, and functional connectivity magnetic resonance imaging – on 17 female patients with fibromyalgia.
The National Institutes of Health estimates that 5 million Americans suffer from fibromyalgia, a poorly understood disorder characterized by chronic deep tissue pain, fatigue, headaches, depression and lack of sleep.
Previous research has shown that fibromyalgia patients may have heightened neural activity in the insula, a region of the brain involved in processing pain and emotion. This excess activity may be related to elevated levels of the neurotransmitter glutamate.
Read more at National Pain Report.
(0) Readers Comments
November 12, 2012
October 08, 2012
September 12, 2012
July 23, 2012
June 11, 2019
April 05, 2019
April 01, 2019
March 18, 2019
Oh boy...Your right we hate to hear this. You know why people in pain
Doesn't the 1.5 billion is spent a year give credence to its possitive
Many MS drugs cause PML and deaths too these drugs all need t
I knew him when he was breaking in at a couple of Los Angeles TV stati
Saying there is a 'twist' is the worst type of spoile